Sparkasse Jena
VC Fund
Jena, Germany
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Sparkasse Jena invests in
Stages Sparkasse Jena invests in
Countries Sparkasse Jena invests in
Investment Focus
Industry
- Medical 3 (38%)
- Health Care 3 (38%)
- Biotechnology 3 (38%)
- Medical Device 3 (38%)
- Shopping 2 (25%)
Stage
- Seed 4 (50%)
- Series A 3 (38%)
- Series C 1 (13%)
Country
- Germany 7 (88%)
- United States 1 (13%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector. | Seed / Jun 30, 2025 | ||
| DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging. | Seed / Feb 17, 2025 | ||
| The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT. | Series A / Jun 05, 2020 | ||
| Dynamic42 provides, customizes innovative 3D microphysiological in vitro test systems recreating human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for preclinical research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems. | Seed / Apr 06, 2020 | ||
| Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib. | $7M / Seed / Feb 03, 2017 | ||
| Jena Cell has a unique and patented technology for the continuous production of a high performance biomaterial with natural nanostructures. | Series A / Jul 12, 2015 | ||
| oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics.The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These markerregions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas. | Series A / Jan 29, 2015 | ||
| Preisbock.de is a “Live Shop†on the internet that each day offers a greatly reduced product for spontaneous sale as “deal of the dayâ€. The offer is valid for up to a week as long as stocks last. The business model is based on cooperation with established retailers and manufacturers. Preisbock.de was founded in July 2007 by dotSource GmbH.Since the beginning of 2008 the portal has been part of Preisbock GmbH, comprising marketing and sales experts who can call on many years of experience in E-commerce. | $1.1M / Series C / Feb 09, 2009 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Sparkasse Jena invest in?
Sparkasse Jena invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Sparkasse Jena last invest?
The most recent investment recorded for Sparkasse Jena closed in Jun 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
